Management of Neonatal Jaundice

Diagnosis and Initial Management

For a term newborn with a bilirubin of 15 mg/dL on day 5 of life, the American Academy of Pediatrics recommends initiating phototherapy immediately using intensive blue light (>30 μW/cm²/nm) and closely monitoring for response, as this level falls within the treatment range for most term infants at this age 1, 2
Measure total serum bilirubin (TSB) to confirm the level and plot it on the hour-specific Bhutani nomogram to determine if it falls in the high-risk zone for this age (120 hours of life), as suggested by the American Academy of Pediatrics 3, 2

The American Academy of Pediatrics recommends starting intensive phototherapy immediately using special blue fluorescent tubes or LED lights delivering irradiance >30 μW/cm²/nm 2, 4
Expect a decrease of >2 mg/dL within 4-6 hours of initiating effective phototherapy; if this does not occur, investigate for hemolysis or other underlying causes, according to the American Academy of Pediatrics 2, 4
Recheck TSB levels 4-6 hours after starting phototherapy to confirm adequate response (>2 mg/dL decrease), as recommended by the American Academy of Pediatrics 2, 4

The American Academy of Pediatrics recommends continuing breastfeeding 8-12 times per day to maintain adequate hydration and caloric intake 3, 2
Do NOT supplement with water or dextrose water as this does not lower bilirubin levels and may interfere with breastfeeding, according to the American Academy of Pediatrics 3

Assess for hemolytic disease by reviewing the blood work for ABO/Rh incompatibility, positive Coombs' test, elevated reticulocyte count, or G6PD deficiency, as recommended by the American Academy of Pediatrics 6, 4
Evaluate breastfeeding adequacy as poor caloric intake and dehydration are common contributors to hyperbilirubinemia at this age, according to the American Academy of Pediatrics 3

The risk of kernicterus at this level in a healthy term infant is low, but the goal of treatment is to prevent further rises that could reach dangerous levels, as stated by the American Academy of Pediatrics 1, 3
Studies show transient neurologic changes can occur at TSB levels of 15-25 mg/dL, though these typically resolve when bilirubin normalizes with treatment, according to the American Academy of Pediatrics 1, 5